Goelzer Investment Management Inc. Sells 1,399 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Goelzer Investment Management Inc. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 21.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,013 shares of the medical equipment provider's stock after selling 1,399 shares during the quarter. Goelzer Investment Management Inc.'s holdings in Intuitive Surgical were worth $2,483,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of ISRG. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after acquiring an additional 243,802 shares during the period. Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter valued at $2,401,493,000. Invesco Ltd. raised its holdings in Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after acquiring an additional 295,025 shares during the period. Finally, Northern Trust Corp raised its holdings in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after acquiring an additional 494,496 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 0.6%

NASDAQ:ISRG traded up $3.14 during midday trading on Friday, hitting $543.74. The company had a trading volume of 704,815 shares, compared to its average volume of 1,672,707. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The stock's fifty day moving average price is $537.11 and its 200-day moving average price is $536.83. The company has a market capitalization of $194.89 billion, a PE ratio of 79.73, a P/E/G ratio of 5.78 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the business earned $1.50 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Evercore ISI lowered their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $588.95.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president directly owned 5,224 shares of the company's stock, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last ninety days. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.